ClinicalTrialsFinder

Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) Clinical Trials in Argenteuil, Île-de-France Region

1 recruitingArgenteuil, Île-de-France Region, France

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Relapsed/Refractory Follicular LymphomaRelapsed/Refractory Marginal Zone Lymphoma (R/R MZL)
Regeneron Pharmaceuticals470 enrolled169 locationsNCT06149286